TomoTherapy

TomoTherapy®, or Helical TomoTherapy, is a commercialized form of CT Guided IMRT or Intensity Modulated Radiation Therapy, which is a new type of radiation therapy delivery system. The Company was developed by Thomas Rockwell Mackie, Ph.D. and Paul Reckwerdt, B.S. at the University of Wisconsin-Madison.

The first clinical use of TomoTherapy was in 2003, there are now more than 150 sites across the United States, Europe and Asia. Lung cancer, head and neck tumors, breast cancer, prostate cancer, stereotactic radiosurgery and stereotactic body radiotherapy are some examples of treatments commonly performed using TomoTherapy.